We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A National Registry of Patients With Hepatocellular Carcinoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00178867
First Posted: September 15, 2005
Last Update Posted: October 10, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Vanderbilt University
  Purpose
A registry of patients with the diagnosis of hepatocellular carcinoma.

Condition
Carcinoma, Hepatocellular

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A National Registry of Patients With Hepatocellular Carcinoma

Further study details as provided by Vanderbilt University:

Enrollment: 150
Study Start Date: January 2002
Study Completion Date: August 2008
Detailed Description:
The purpose of this research is to study the factors which might cause hepatocellular carcinoma (a form of cancer arising within the liver) and compare these factors in patients from different ethnic groups and from different parts of the United States. The researchers will also conduct a survey of the stage of the cancer (how far advanced it is) and what treatments are used for this difficult-to-treat tumor.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients seen in Hepatobiliary Surgery Clinic at Vanderbilt University Medical Center who are diagnosed with hepatocellular carcinoma.
Criteria

Inclusion Criteria:

  • Patients with diagnosis of hepatocellular carcinoma

Exclusion Criteria:

  • Patients can not be under 18 years of age
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00178867


Locations
United States, Tennessee
Vanderbilt University
Nashville, Tennessee, United States, 37232-4753
Sponsors and Collaborators
Vanderbilt University
Investigators
Principal Investigator: Ravi S Chari, MD Vanderbilt University
  More Information

Responsible Party: Ravi Chari, MD, Vanderbilt University
ClinicalTrials.gov Identifier: NCT00178867     History of Changes
Other Study ID Numbers: 020116
First Submitted: September 12, 2005
First Posted: September 15, 2005
Last Update Posted: October 10, 2008
Last Verified: October 2008

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Hepatocellular
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Adenocarcinoma
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Liver Diseases